5.08
Precedente Chiudi:
$5.12
Aprire:
$5.03
Volume 24 ore:
3.44M
Relative Volume:
0.58
Capitalizzazione di mercato:
$901.56M
Reddito:
$2.54B
Utile/perdita netta:
$-207.36M
Rapporto P/E:
-4.2689
EPS:
-1.19
Flusso di cassa netto:
$151.25M
1 W Prestazione:
-3.42%
1M Prestazione:
+1.40%
6M Prestazione:
-35.04%
1 anno Prestazione:
-45.90%
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
5.08 | 908.66M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
195.49 | 32.23B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.26 | 9.48B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.49 | 8.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.36 | 6.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
25.71 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-07-25 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Trading the Move, Not the Narrative: (TDOC) Edition - Stock Traders Daily
Teladoc Health joins Eli Lilly Employer Connect platform to expand workplace health options - Traders Union
Hims and Hers Expands Its Technology Driven Consumer Health Platform - TradingView
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 - The Manila Times
New Teladoc growth chief gets stock tied to 3-year targets - Stock Titan
Teladoc Health CLO sold $138,583 in TDOC stock - Investing.com Nigeria
Teladoc Health CLO sold $138,583 in TDOC stock By Investing.com - Investing.com Australia
How Do Investors Really Feel About Teladoc Health Inc? - Benzinga
[Form 4] Teladoc Health, Inc. Insider Trading Activity - Stock Titan
Teladoc Health (NYSE: TDOC) CEO reports stock sale and major equity grants - Stock Titan
Teladoc (TDOC) CAO sells shares, receives RSU and PSU grants - Stock Titan
Teladoc (NYSE: TDOC) executive sells shares and receives large equity awards - Stock Titan
Barclays healthcare conference to feature Teladoc CEO webcast March 10 - Stock Titan
Teladoc Health (NYSE:TDOC) Russell 1000 Drops on Target Cut - Kalkine Media
Teladoc Health (TDOC): Oppenheimer Adjusts Price Target Amidst C - GuruFocus
Teladoc Health (TDOC) Analyst Rating: Citigroup Lowers Price Tar - GuruFocus
Teladoc Health (NYSE:TDOC) Price Target Cut to $6.00 by Analysts at Citigroup - MarketBeat
Fernando Rodrigues (TDOC) files to sell 25,086 vested shares on NYSE - Stock Titan
Oppenheimer Cuts Teladoc Health (NYSE:TDOC) Price Target to $7.00 - MarketBeat
Oppenheimer Adjusts Price Target on Teladoc Health to $7 From $12, Maintains Outperform Rating - marketscreener.com
Vanguard Group Inc. Raises Stock Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health, Inc. (TDOC) Stock Analysis: A Look at the 41% Potential Upside for Investors - DirectorsTalk Interviews
Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
TDOC (Teladoc Health) Days Payable : 25.99 (As of Sep. 2025) - GuruFocus
Teladoc (NYSE: TDOC) executive sale covers taxes and adds 173,010 RSUs - Stock Titan
Teladoc Health, Inc. expands virtual care to meet broad employee needs for VSP Vision - Traders Union
[144] Teladoc Health, Inc. SEC Filing - Stock Titan
26,647-share Form 144 notice for TDOC (NYSE: TDOC) by Fidelity - Stock Titan
27,083-Share Vesting Sale Filed by TDOC (NYSE: TDOC) - Stock Titan
Carlos Nueno Plana to sell 20,165 TDOC shares via Fidelity (TDOC) - Stock Titan
Teladoc Health Q4 Earnings Call Highlights - Yahoo Finance
A Look At Teladoc Health’s Valuation As 2025 Results And 2026 Outlook Refocus Attention On The Stock - simplywall.st
UBS Adjusts Price Target on Teladoc Health to $6 From $9, Maintains Neutral Rating - marketscreener.com
TDOC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Insider sale notice: TDOC (NYSE: TDOC) 50,145 restricted shares - Stock Titan
Teladoc Health Q4 Loss Narrows To US$25 Million Challenging Bearish Profitability Narratives - simplywall.st
BofA Securities Upgrades Teladoc Health, Inc. (TDOC) to Buy Feb 26, 2026 - Meyka
Teladoc Health Q4 2025 Earnings: Revenue Beat, Weak 2026 GuidanceNews and Statistics - IndexBox
Canaccord Genuity Group Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
Teladoc Health (TDOC) Analyst Rating Maintained, Price Target Lo - GuruFocus
Teladoc projects lower integrated care membership amid ACA subsidy lapse - Healthcare Dive
Teladoc Health (TDOC) Surges 14% After Beating Q4 2025 Estimates - GuruFocus
Demystifying Teladoc Health: Insights From 8 Analyst Reviews - Benzinga
TDOC: BMO Capital Lowers Price Target, Maintains Market Perform Rating | TDOC Stock News - GuruFocus
Teladoc Health (NYSE:TDOC) Given New $6.00 Price Target at TD Cowen - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
These Analysts Slash Their Forecasts On Teladoc Health After Q4 Results - Benzinga
Why Teladoc (TDOC) Stock Is Up Today - Yahoo Finance
BofA upgrades Teladoc stock rating on BetterHelp margin outlook By Investing.com - Investing.com Canada
Teladoc Health (NYSE:TDOC) Stock Rating Upgraded by Bank of America - MarketBeat
TDOC's Price Target Lowered by Piper Sandler Amid Overweight Rat - GuruFocus
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):